Akums is among the largest domestic market-focused Indian CDMOs on a revenue basis serving IPM, with a market share of 9.3% by value in FY23 in the total addressable Indian domestic CDMO market and 8.8% by volume in the total IPM market in FY23.
Akums, a Book Built Issue amounting to ₹1,856.73 crores, consisting a Fresh Issue of 100.14 Lakh Shares worth ₹680.00 Crores and an Offer for Sale of 173.30 Lakh Shares totalling to ₹1,176.73 Crores. The subscription period for the Akums IPO opens on July 30, 2024, and closes on August 01, 2024. The allotment is expected to be finalized on or about Friday, August 02, 2024, and the shares will be listed on the BSE NSE with a tentative listing date set on or about Tuesday, August 06, 2024.
The Share price band of Akums IPO is set at ₹646 to ₹679 equity per share, with a minimum lot size of 22 shares. Retail investors are required to invest a minimum of ₹14,938, while the minimum investment for High-Net-Worth Individuals (HNIs) is 14 lots (308 shares), amounting to ₹209,132.
ICICI Securities Limited, Axis Capital Limited, Citigroup Global Markets India Private Limited and Ambit Private Limited are the book-running lead manager, Link Intime India Private Limited is the registrar for the Issue.
Akums Drugs and Pharmaceuticals Limited IPO GMP Today
The Grey Market Premium of Akums Drugs and Pharmaceuticals Limited IPO is expected in the range of ₹70 to ₹100 based on the financial performance of the company. No real trading is done on the basis of Grey Market Premium that's why no real discovery of price can be done before the listing of shares on the stock exchange. The Grey Market Premium totally depends upon the Demand and Supply of the shares of the company in unorganized manner which is not recommended. The Grey Market Premium is mentioned for educational and informational purposes only.
Akums Drugs and Pharmaceuticals Limited IPO Live Subscription Status Today
As of 09:28 PM on 01 August 2024, the Akums Drugs and Pharmaceuticals Limited IPO live subscription status shows that the IPO subscribed 63.56 times on on the final day of subscription period. Check the Akums Drugs and Pharmaceuticals Limited IPO Live Subscription Status Today at NSE.
Akums Drugs and Pharmaceuticals Limited IPO Allotment Status
Akums IPO allotment date is 02 August, 2024, Friday. Akums IPO Allotment will be out on 2nd August 2024 and will be live on Registrar Website from the allotment date. Check Akums Drugs and Pharmaceuticals Limited IPO Allotment Status here. Here's how you can check the allotment status:
- Navigate to the IPO allotment status page.
- Select Akums Drugs and Pharmaceuticals Limited IPO from the dropdown list of IPOs.
- Enter your application number, PAN, or DP Client ID.
- Submit the details to check your allotment status.
By following either of these methods, investors can quickly determine their allotment status and proceed accordingly with their investments.
Objectives of Akums Drugs and Pharmaceuticals Limited IPO
Akums Issue Proceeds from the Fresh Issue will be utilized towards the following objects :
a. ₹1,599.10 Millions is required for Repayment/ prepayment of indebtedness of their Company;
b. ₹2,270.90 Millions is required for Repayment/ prepayment of indebtedness of their Subsidiaries namely, Maxcure Nutravedics Limited and Pure and Cure Healthcare Private Limited;
c. ₹550.00 Millions is required for Funding incremental working capital requirements of our Company;
d. Pursuing inorganic growth initiatives through acquisitions; and
e. General corporate purposes.
Refer to Akums Drugs and Pharmaceuticals Limited RHP for more details about the Company.
FNO Stocks with CA Abhay
Option Trading with CA Abhay
Equity Investment with CA Abhay
Stock Market Masterclass
Equity Trading with CA Abhay
FNO Stocks with CA Abhay
Equity Investment with CA Abhay
Option Trading with CA Abhay
Equity Trading with CA Abhay
Stock Market Masterclass
Copyright @2020 Design & Developed by Info Web Software